Showing 881-890 of 10608 results for "".
Innovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroTo Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Social Media Success Strategies
https://practicaldermatology.com/topics/practice-management/social-media-success-strategies/20191/Doris Day, MD, shares some best practices on using social media to educate patients and dispel myths perpetuated by ‘skinfluencers’.Weighing the Safety of Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-safety-of-sunscreens/20172/Adam Friedman, MD, provides compelling reasons to question the recent studies on sunscreen safety.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyAttend High-Quality Sessions at DERM2021
https://practicaldermatology.com/series/dermatology-education-foundation/attend-high-quality-sessions-at-derm2021/19966/Sandri Johnson, FNP-BC says she’s looking forward to attending this year’s DERM2021 NP/PA CME Conference, interacting with colleagues face-to-face, and going to high-quality, educational sessions to learn about what’s new in dermatology.Scientifically Speaking: New Directions in Acne Management, Part 1
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-new-directions-in-acne-management-part-1/19939/The recognition that inflammation is at the heart of acne has led to changes in management approaches and better understanding of how treatments work. In the first of a 2-part series, host Joel L. Cohen, MD talks to Diane Berson, MD; Linda Stein Gold, MD; and Emil Tanghetti, MD about acne approachesScientifically Speaking: Sunscreen Facts from Steven Wang, MD
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-sunscreen-facts-from-steven-wang-md/19862/Which sunscreen ingredients work best? How can dermatologists get patients to apply properly? And what is the role for sun protective clothing? Host Joel L. Cohen, MD talks to Steven Wang, MD, about facts and misconceptions in the science of sun protection.South Beach Bums
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/south-beach-bums/19707/Today's technology allow for buttock lifting. Key is to identify the right candidates, set expectations, and use the right devices, says Manjula Jegasothy, MD